Before leaving Honolulu, make plans with your colleagues to reconvene for CHEST 2024, October 6-9, in Boston, MA.

Lisa Moores, MD, FCCP, helped guide audience members through a case study of intermediate-risk pulmonary embolism that involved various choices for risk stratification and therapy.

Panelists, including Max Hockstein, MD, MS, provided an overview of the available tools for determining the etiology of shock and their real-world usage.

A Wednesday morning session, chaired by Thomas DeCato, MD, FCCP, will help clinicians navigate the current guidance for pulmonary function tests, address controversial issues, and answer unresolved questions from their daily practice.

A Wednesday morning panel discussion, chaired by Sean Callahan, MD, will help attendees distinguish incidental interstitial lung abnormalities from more consequential findings such as interstitial lung disease.

Listen now for a preview of the day from Chair of the Scientific Program Committee, Aneesa Das, MD, FCCP, and her guest, Chair of CHEST 2024, Gabriel T. Bosslet, MD, FCCP.

A Wednesday morning discussion session co-chaired by Kathryn Pendleton, MD, FCCP, will look at the current problems and opportunities with the use of artificial intelligence to identify patients with sepsis or predict the onset of sepsis.

George Z. Cheng, MD, PhD, FCCP, will chair a debate that will explore the need for improved safety and efficacy data, lessons that can be learned from other disciplines, and pitfalls that might be avoided.

A pro-con debate session chaired by Daniel Ouellette, MD, MS, FCCP, will help physicians navigate their way through decisions about when, how, and who to liberate from mechanical ventilation.

Experts will present three challenging but frequently encountered clinical preoperative scenarios for audience consideration during an innovative session chaired by Arun Jose, MD, MS.

A discussion session, chaired by Radu Postelnicu, MD, will arm attendees with the latest knowledge about highly transmissible diseases that have the potential to cause significant fallout worldwide.

Ryan Boente, MD, will co-chair a panel discussion addressing the disparities that exist for patients with interstitial lung disease (ILD) who live in rural areas.